Evidence map›Paper›PMID 21696367›Full record

ArticleThe Biochemical journal2011

Autotaxin induces lung epithelial cell migration through lysoPLD activity-dependent and -independent pathways.

Jing Zhao, Donghong He, Evgeny Berdyshev, Mintao Zhong, Ravi Salgia, Andrew J Morris, Susan S Smyth, Viswanathan Natarajan, Yutong Zhao

Abstract read
In one paragraph

Article in The Biochemical journal, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Review
  3. Designing Dual Inhibitors of Autotaxin-LPAR GPCR Axis.Molecules (Basel, Switzerland) · 2022
    Review
  4. Cortactin in Lung Cell Function and Disease.International journal of molecular sciences · 2022
    Review
  5. Article
  6. Lysophospholipids in Lung Inflammatory Diseases.Advances in experimental medicine and biology · 2021
    Article
  7. The roles of autotaxin/lysophosphatidic acid in immune regulation and asthma.Biochimica et biophysica acta. Molecular and cell biology of lipids · 2020
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Observational
  15. Article
  16. Review
  17. Article
  18. Autotaxin-LPA receptor axis in the pathogenesis of lung diseases.International journal of clinical and experimental medicine · 2015
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Jing ZhaoDepartment of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.
Donghong He
Evgeny Berdyshev
Mintao Zhong
Ravi Salgia
Andrew J Morris
Susan S Smyth
Viswanathan Natarajan
Yutong Zhao
University of Illinois Chicago · USUniversity of Pittsburgh · USUniversity of Kentucky · USUniversity of Chicago · US

Funding

Lysophosphatidic Acid in Airway Barrier Function and RemodelingR01HL091916 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ZHAO, YUTONG · 2009 to 2013
$1.8M
Intracellular S1P &signaling in lung endothelial cellsR01HL079396 · NHLBI · UNIVERSITY OF CHICAGO · PI NATARAJAN, VISWANATHAN · 2005 to 2009
$1.8M
Thermo/Finnigan TSQ AM Triple Stage Quadrupole Mass SpectrometerS10RR024598 · NCRR · UNIVERSITY OF KENTUCKY · PI MORRIS, ANDREW J · 2008 to 2008
$493k
Protective Role of Intracellular S1P in Lung InjuryR37HL079396 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI NATARAJAN, VISWANATHAN · 2010 to 2010
$393k
NCRR NIH HHS S10 RR024598NHLBI NIH HHS HL079396NHLBI NIH HHS HL0911916NHLBI NIH HHS R01 HL079396NHLBI NIH HHS R01 HL091916NHLBI NIH HHS R37 HL079396
6 · The paper itself

Abstract

Lung cell migration is a crucial step for re-epithelialization that in turn is essential for remodelling and repair after lung injury. In the present paper we hypothesize that secreted ATX (autotaxin), which exhibits lysoPLD (lysophospholipase D) activity, stimulates lung epithelial cell migration through LPA (lysophosphatidic acid) generation-dependent and -independent pathways. Release of endogenous ATX protein and activity was detected in lung epithelial cell culture medium. ATX with V5 tag overexpressed conditional medium had higher LPA levels compared with control medium and stimulated cell migration through G(αi)-coupled LPA receptors, cytoskeleton rearrangement, phosphorylation of PKC (protein kinase C) δ and cortactin at the leading edge of migrating cells. Inhibition of PKCδ attenuated ATX-V5 overexpressed conditional medium-mediated phosphorylation of cortactin. In addition, a recombinant ATX mutant, lacking lysoPLD activity, or heat-inactived ATX also induced lung epithelial cell migration. Extracelluar ATX bound to the LPA receptor and integrin β4 complex on A549 cell surface. Finally, intratracheal administration of LPS (lipopolysaccharide) into the mouse airway induced ATX release and LPA production in BAL (bronchoalveolar lavage) fluid. These results suggested a significant role for ATX in lung epithelial cell migration and remodelling through its ability to induce LPA production-mediated phosphorylation of PKCδ and cortactin. In addition we also demonstrated association of ATX with the epithelial cell-surface LPA receptor and integrin β4.

Indexed as

AnimalsBlotting, WesternBronchoalveolar Lavage FluidCell LineCell Line, TumorCell MovementHumansImmunoprecipitationIntegrin beta4LipopolysaccharidesLungLysophospholipase DLysophospholipidsMaleMiceMicroscopy, FluorescenceIntegrin beta4Lipopolysaccharideslysophosphatidic acidLysophospholipase DLysophospholipidsPhosphoric Diester HydrolasesReceptors, Lysophosphatidic Acid

Identifiers

PMID21696367
PMCPMC3674636
OpenAlexW2079267349

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.